{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:41:32Z","timestamp":1740152492115,"version":"3.37.3"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA16058"],"award-info":[{"award-number":["P30 CA16058"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinical-colorectal-cancer.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clcc.2024.01.004","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T09:47:20Z","timestamp":1706608040000},"page":"160-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4931-3521","authenticated-orcid":false,"given":"Eric D.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett G.","family":"Klamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan M.","family":"Cloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn E.","family":"Hitchcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B.","family":"Romesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey J.","family":"Mamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimmie","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George J.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2024.01.004_bib0001","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2468-1253(22)00044-9","article-title":"Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0002","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00384-014-2085-6","article-title":"Metachronous metastases from colorectal cancer: a population-based study in north-east Netherlands","volume":"30","author":"Elferink","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.clcc.2024.01.004_bib0003","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41698-023-00353-4","article-title":"Survival improvement for patients with metastatic colorectal cancer over twenty years","volume":"7","author":"Zeineddine","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0004","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","article-title":"Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy","volume":"27","author":"Kopetz","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00000658-200206000-00002","article-title":"Trends in long-term survival following liver resection for hepatic colorectal metastases","volume":"235","author":"Choti","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.clcc.2024.01.004_bib0006","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1200\/JCO.2016.72.1464","article-title":"Impact of recurrence and salvage surgery on survival after multidisciplinary treatment of rectal cancer","volume":"35","author":"Ikoma","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0007","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/annonc\/mds053","article-title":"Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: A randomized EORTC intergroup phase II study (EORTC 40004)","volume":"23","author":"Ruers","year":"2012","journal-title":"Annals Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0008","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx015","article-title":"Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial - PubMed (nih.gov)","volume":"109","author":"Ruers","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clcc.2024.01.004_bib0009","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1245\/s10434-015-4979-0","article-title":"Outcomes of resected colorectal cancer lung metastases in routine clinical practice: a population-based study","volume":"23","author":"Booth","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0010","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1245\/s10434-012-2726-3","article-title":"Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis","volume":"20","author":"Gonzalez","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0011","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/codi.15113","article-title":"Pulmonary metastasectomy in colorectal cancer: updated analysis of 93 randomized patients\u2014control survival is much better than previously assumed","volume":"22","author":"Milosevic","year":"2020","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.clcc.2024.01.004_bib0012","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1245\/s10434-017-5897-0","article-title":"Short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical treatment in primary stage IV rectal cancer: long-term results of a phase II study","volume":"24","author":"Bisschop","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0013","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/annonc\/mdt124","article-title":"Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer","volume":"24","author":"van Dijk","year":"2013","journal-title":"Annals Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0014","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1245\/s10434-016-5189-0","article-title":"Survival following resection of intra- and extra-hepatic metastases from colorectal cancer: a phase II trial","volume":"23","author":"Wei","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijrobp.2022.05.004","article-title":"Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET): extended long-term outcomes","volume":"114","author":"Harrow","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2024.01.004_bib0016","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0017","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejca.2020.08.009","article-title":"Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy-a pooled analysis of tribe and tribe2 studies by gruppo oncologico del nord ovest","volume":"139","author":"Moretto","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2024.01.004_bib0018","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for radiotherapy and oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0019","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0020","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s12029-022-00900-5","article-title":"Oligometastatic colorectal cancer: a review of definitions and patient selection for local therapies","volume":"54","author":"Miller","year":"2023","journal-title":"J Gastrointest Cancer"},{"year":"2019","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","key":"10.1016\/j.clcc.2024.01.004_bib0021"},{"key":"10.1016\/j.clcc.2024.01.004_bib0022","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/SLA.0000000000002353","article-title":"Laparoscopic versus open resection for colorectal liver metastases: the OSLO-COMET randomized controlled trial","volume":"267","author":"Fretland","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.clcc.2024.01.004_bib0023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/SLA.0000000000003848","article-title":"Simultaneous versus delayed resection for initially resectable synchronous colorectal cancer liver metastases: a prospective, open-label, randomized, controlled trial","volume":"273","author":"Boudjema","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.clcc.2024.01.004_bib0024","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.21037\/jtd.2019.12.12","article-title":"A systematic review and meta-analysis of stereotactic body radiation therapy for colorectal pulmonary metastases","volume":"11","author":"Cao","year":"2019","journal-title":"J thorac dis"},{"key":"10.1016\/j.clcc.2024.01.004_bib0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1470-2045(20)30537-4","article-title":"Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study","volume":"22","author":"Chalkidou","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0026","first-page":"1188","article-title":"Tumor control and overall survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal cancer: a meta-analysis","volume":"52","author":"Choi","year":"2020","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.clcc.2024.01.004_bib0027","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.surg.2011.12.009","article-title":"Impact of subcentimeter margin on outcome after hepatic resection for colorectal metastases: a meta-regression approach","volume":"151","author":"Cucchetti","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.clcc.2024.01.004_bib0028","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1002\/cam4.2515","article-title":"Parenchymal-sparing versus extended hepatectomy for colorectal liver metastases: a systematic review and meta-analysis","volume":"8","author":"Deng","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.clcc.2024.01.004_bib0029","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.clon.2016.02.001","article-title":"Exploratory analysis on overall survival after either surgery or stereotactic radiotherapy for lung oligometastases from colorectal cancer","volume":"28","author":"Filippi","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clcc.2024.01.004_bib0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10585-020-10047-x","article-title":"Phase II trial of high dose stereotactic body radiation therapy for lymph node oligometastases","volume":"37","author":"Franzese","year":"2020","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.clcc.2024.01.004_bib0031","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21037\/cco.2020.01.10","article-title":"Long term control stereotactic body radiotherapy (SBRT) for oligometastatic colorectal cancer: a single center study","volume":"9","author":"Gil-Raga","year":"2020","journal-title":"Chin clin oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0032","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.prro.2015.10.011","article-title":"Long-term safety and efficacy of stereotactic body radiation therapy for hepatic oligometastases","volume":"6","author":"Goodman","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0033","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/02841860600904854","article-title":"Phase II study on stereotactic body radiotherapy of colorectal metastases","volume":"45","author":"Hoyer","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0034","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jamaoncol.2020.6146","article-title":"Safety and survival rates associated with ablative stereotactic radiotherapy for patients with oligometastatic cancer: a systematic review and meta-analysis","volume":"7","author":"Lehrer","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0035","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00384-015-2323-6","article-title":"Negative surgical margin improved long-term survival of colorectal cancer liver metastases after hepatic resection: a systematic review and meta-analysis","volume":"30","author":"Liu","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.clcc.2024.01.004_bib0036","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/SLA.0000000000002552","article-title":"Impact of surgical margin width on recurrence and overall survival following R0 hepatic resection of colorectal metastases: a systematic review and meta-analysis","volume":"267","author":"Margonis","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.clcc.2024.01.004_bib0037","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijrobp.2017.04.010","article-title":"Long-term outcomes of phase 1 and 2 studies of SBRT for hepatic colorectal metastases","volume":"99","author":"McPartlin","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2024.01.004_bib0038","first-page":"43","article-title":"Patients with colorectal lung oligometastases (l-omd) treated by dose adapted SABR at diagnosis of oligometastatic disease have better outcomes than patients previously treated for their metastatic disease","volume":"5","author":"Mihai","year":"2017","journal-title":"J Radiosurg SBRT"},{"key":"10.1016\/j.clcc.2024.01.004_bib0039","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2014.10.021","article-title":"Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study","volume":"91","author":"Nuyttens","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2024.01.004_bib0040","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/02841860600908954","article-title":"Stereotactic body radiation therapy (SBRT) for lung metastases","volume":"45","author":"Okunieff","year":"2006","journal-title":"Acta Oncol (Stockholm, Sweden)"},{"key":"10.1016\/j.clcc.2024.01.004_bib0041","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.radonc.2018.06.035","article-title":"Stereotactic body radiotherapy for colorectal cancer liver metastases: a systematic review","volume":"129","author":"Petrelli","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0042","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00432-014-1833-x","article-title":"Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer","volume":"141","author":"Scorsetti","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0043","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.adro.2018.09.001","article-title":"Stereotactic ablative radiation therapy for unresectable colorectal oligometastases","volume":"4","author":"Sutera","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0044","doi-asserted-by":"crossref","first-page":"32304","DOI":"10.1038\/srep32304","article-title":"Comparison of anatomical and nonanatomical hepatectomy for colorectal liver metastasis: a meta-analysis of 5207 patients","volume":"6","author":"Tang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.clcc.2024.01.004_bib0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7326\/M20-4011","article-title":"Long-term oncologic outcomes after laparoscopic versus open resection for colorectal liver metastases: a randomized trial","volume":"174","author":"Aghayan","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clcc.2024.01.004_bib0046","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.surg.2006.07.045","article-title":"Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases","volume":"141","author":"Antoniou","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.clcc.2024.01.004_bib0047","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1245\/s10434-014-4354-6","article-title":"Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis","volume":"22","author":"Araujo","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0048","first-page":"373","article-title":"The effect of radiofrequency ablation vs. liver resection on survival outcome of colorectal liver metastases (CRLM): a meta-analysis","volume":"62","author":"Bai","year":"2015","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.clcc.2024.01.004_bib0049","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1200\/JCO.2010.32.6132","article-title":"High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome","volume":"29","author":"Brouquet","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0050","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jss.2017.05.110","article-title":"Laparoscopic versus open liver resection for colorectal liver metastases: a systematic review","volume":"220","author":"Cheng","year":"2017","journal-title":"J Surg Res"},{"key":"10.1016\/j.clcc.2024.01.004_bib0051","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00464-019-06774-2","article-title":"A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and open liver resections for liver metastases from colorectal cancer","volume":"34","author":"Ciria","year":"2020","journal-title":"Surg Endosc"},{"key":"10.1016\/j.clcc.2024.01.004_bib0052","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ejso.2019.12.003","article-title":"Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases","volume":"46","author":"Di Martino","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0053","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13063-015-0577-5","article-title":"Open versus laparoscopic liver resection for colorectal liver metastases (the OSLO-COMET study): study protocol for a randomized controlled trial","volume":"16","author":"Fretland","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.clcc.2024.01.004_bib0054","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ijrobp.2019.02.033","article-title":"Phenotype-oriented ablation of oligometastatic cancer with single dose radiation therapy","volume":"104","author":"Greco","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2024.01.004_bib0055","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.4103\/0366-6999.195470","article-title":"Radiofrequency ablation versus liver resection for colorectal cancer liver metastasis: an updated systematic review and meta-analysis","volume":"129","author":"Han","year":"2016","journal-title":"Chin Med J"},{"key":"10.1016\/j.clcc.2024.01.004_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.561669","article-title":"Can radiofrequency ablation replace liver resection for solitary colorectal liver metastasis? A systemic review and meta-analysis","volume":"10","author":"Hao","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0057","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ijc.31114","article-title":"Relevance of liver-limited disease in metastatic colorectal cancer: subgroup findings of the FIRE-3\/AIO krk0306 trial","volume":"142","author":"Holch","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2024.01.004_bib0058","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.surg.2018.01.020","article-title":"Laparoscopic versus open major hepatectomy: a systematic review and meta-analysis of individual patient data","volume":"163","author":"Kasai","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.clcc.2024.01.004_bib0059","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00432-020-03142-9","article-title":"Peri-operative chemotherapy for resectable colorectal lung metastasis: a systematic review and meta-analysis","volume":"146","author":"Li","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0060","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1177\/000313481808401237","article-title":"Meta-analysis of long-term outcomes in patients with colorectal liver metastases undergoing hepatectomy with or without radiofrequency ablation","volume":"84","author":"Long","year":"2018","journal-title":"Am Surg"},{"key":"10.1016\/j.clcc.2024.01.004_bib0061","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ejso.2014.03.012","article-title":"Selecting patients for a second hepatectomy for colorectal metastases: an systemic review and meta-analysis","volume":"40","author":"Luo","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0062","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC intergroup trial 40983): a randomised controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.clcc.2024.01.004_bib0063","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial","volume":"14","author":"Nordlinger","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0064","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1245\/s10434-012-2438-8","article-title":"Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis","volume":"19","author":"Robinson","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0065","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1007\/s00464-019-06679-0","article-title":"Open versus minimally invasive liver surgery for colorectal liver metastases (lapophuva): a prospective randomized controlled trial","volume":"33","author":"Robles-Campos","year":"2019","journal-title":"Surg Endosc"},{"key":"10.1016\/j.clcc.2024.01.004_bib0066","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ejca.2013.12.008","article-title":"Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983","volume":"50","author":"Tanis","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2024.01.004_bib0067","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.hpb.2017.05.011","article-title":"Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases\u2014a meta-analysis","volume":"19","author":"van Amerongen","year":"2017","journal-title":"HPB"},{"key":"10.1016\/j.clcc.2024.01.004_bib0068","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.hbpd.2019.02.003","article-title":"Survival after repeat hepatectomy for recurrent colorectal liver metastasis: a review and meta-analysis of prognostic factors","volume":"18","author":"Wang","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.clcc.2024.01.004_bib0069","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.hpb.2017.02.440","article-title":"A systematic review and meta-analysis of the utility of repeated versus single hepatic resection for colorectal cancer liver metastases","volume":"19","author":"Wurster","year":"2017","journal-title":"HPB"},{"key":"10.1016\/j.clcc.2024.01.004_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105896","article-title":"The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: a systematic review and meta-analysis based on 22 studies","volume":"87","author":"Yang","year":"2021","journal-title":"Int J Surg"},{"key":"10.1016\/j.clcc.2024.01.004_bib0071","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ejso.2018.03.011","article-title":"Individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: a history of resected liver metastases worsens the prognosis","volume":"44","author":"Zabaleta","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0072","article-title":"Ten-year survival after liver resection for colorectal metastases: systematic review and meta-analysis","volume":"2011","author":"Abbas","year":"2011","journal-title":"ISRN oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0073","doi-asserted-by":"crossref","unstructured":"Brudvik KW, Kopetz SE, Li L, et al. Meta-analysis of kras mutations and survival after resection of colorectal liver metastases Br J Surg. 2015;102:1175-83. https:\/\/doi.org\/10.1002\/bjs.9870","DOI":"10.1002\/bjs.9870"},{"key":"10.1016\/j.clcc.2024.01.004_bib0074","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.hpb.2019.10.003","article-title":"Primary tumor location and the prognosis of patients after local treatment of colorectal liver metastases: a systematic review and meta-analysis","volume":"22","author":"Buisman","year":"2020","journal-title":"HPB"},{"key":"10.1016\/j.clcc.2024.01.004_bib0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejca.2017.04.024","article-title":"First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: a randomised, phase II trial (planet-ttd)","volume":"81","author":"Carrato","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2024.01.004_bib0076","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/ajco.12692","article-title":"Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial","volume":"14","author":"Chen","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0077","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejca.2016.02.003","article-title":"Management of liver metastases in colorectal cancer patients: a retrospective case-control study of systemic therapy versus liver resection","volume":"59","author":"de Ridder","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2024.01.004_bib0078","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/annonc\/mdt537","article-title":"Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival","volume":"25","author":"de Vin","year":"2014","journal-title":"Annals Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0079","article-title":"Surgical and regional treatments for colorectal cancer metastases in older patients: a systematic review and meta-analysis","volume":"15","author":"de'Angelis","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clcc.2024.01.004_bib0080","doi-asserted-by":"crossref","first-page":"S1259","DOI":"10.21037\/jtd.2017.04.44","article-title":"Prognostic factors after pulmonary metastasectomy of colorectal cancers: a single-center experience","volume":"9","author":"Fournel","year":"2017","journal-title":"J thorac dis"},{"key":"10.1016\/j.clcc.2024.01.004_bib0081","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217411","article-title":"Primary tumour location affects survival after resection of colorectal liver metastases: a two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score","volume":"14","author":"Gasser","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.clcc.2024.01.004_bib0082","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.hpb.2015.12.004","article-title":"Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomes","volume":"18","author":"Hadden","year":"2016","journal-title":"HPB"},{"key":"10.1016\/j.clcc.2024.01.004_bib0083","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.ejso.2019.04.017","article-title":"The primary tumor location impacts survival outcome of colorectal liver metastases after hepatic resection: a systematic review and meta-analysis","volume":"45","author":"Liu","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0084","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1245\/s10434-019-07976-7","article-title":"Fong's score in the era of modern perioperative chemotherapy for metastatic colorectal cancer: a post hoc analysis of the GERCOR-MIROX phase III trial","volume":"27","author":"Makhloufi","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0085","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clcc.2024.01.004_bib0086","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.critrevonc.2015.12.015","article-title":"Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis","volume":"99","author":"Passiglia","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0087","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/ans.13211","article-title":"Hepatic resection for malignant liver tumours in the elderly: a systematic review and meta-analysis","volume":"85","author":"Phan","year":"2015","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.clcc.2024.01.004_bib0088","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/annonc\/mds100","article-title":"Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model","volume":"23","author":"Salah","year":"2012","journal-title":"Annals Oncol Off J Eur Soc Med Oncoly"},{"key":"10.1016\/j.clcc.2024.01.004_bib0089","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/bjs.6735","article-title":"Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases","volume":"96","author":"Smith","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.clcc.2024.01.004_bib0090","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1200\/JCO.20.00174","article-title":"Bevacizumab plus mFOLFOX6 versus mFOLFOX6 alone as first-line treatment for RAS mutant unresectable colorectal liver-limited metastases: the become randomized controlled trial","volume":"38","author":"Tang","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0091","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.clcc.2017.01.004","article-title":"Effect of KRAS and BRAF mutations on survival of metastatic colorectal cancer after liver resection: a systematic review and meta-analysis","volume":"16","author":"Tosi","year":"2017","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clcc.2024.01.004_bib0092","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000487274","article-title":"Systematic review and meta-analysis of liver resection for colorectal metastases in elderly patients","volume":"36","author":"van Tuil","year":"2019","journal-title":"Dig Surg"},{"key":"10.1016\/j.clcc.2024.01.004_bib0093","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/bjs.11289","article-title":"Meta-analysis of the association between primary tumour location and prognosis after surgical resection of colorectal liver metastases","volume":"106","author":"Wang","year":"2019","journal-title":"Br J Surg"},{"key":"10.1016\/j.clcc.2024.01.004_bib0094","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00384-019-03386-z","article-title":"Lung metastasectomy after colorectal cancer: prognostic impact of resection margin on long term survival, a retrospective cohort study","volume":"35","author":"Davini","year":"2020","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.clcc.2024.01.004_bib0095","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.athoracsur.2017.03.021","article-title":"Surgical outcome and prognostic stratification for pulmonary metastasis from colorectal cancer","volume":"104","author":"Okumura","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.clcc.2024.01.004_bib0096","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1245\/s10434-015-4925-1","article-title":"Surgical resection preferences and perceptions among medical oncologists treating liver metastases from colorectal cancer","volume":"23","author":"Choti","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0097","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1200\/JCO.22.01690","article-title":"Treatment of metastatic colorectal cancer: ASCO guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2024.01.004_bib0098","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1002\/cncr.34931","article-title":"American radium society appropriate use criteria for the use of liver-directed therapies for nonsurgical management of liver metastases: systematic review and guidelines","volume":"129","author":"Hallemeier","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2024.01.004_bib0099","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/DCR.0000000000000684","article-title":"Insurance status and hospital payer mix are linked with variation in metastatic site resection in patients with advanced colorectal cancers","volume":"59","author":"Healy","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2024.01.004_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263818","article-title":"The association of health insurance and race with treatment and survival in patients with metastatic colorectal cancer","volume":"17","author":"Mitsakos","year":"2022","journal-title":"PLoS One"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002824000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002824000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T12:53:26Z","timestamp":1717332806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002824000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1533002824000045"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2024.01.004","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2024.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}